Literature DB >> 12063395

Conservation of RET proto-oncogene splicing variants and implications for RET isoform function.

M T Carter1, J L Yome, M N Marcil, C A Martin, J B Vanhorne, L M Mulligan.   

Abstract

The RET proto-oncogene encodes a receptor tyrosine kinase required for development of the kidney and neural crest-derived cell types. Alternative splicing of the 3' exons of human RET results in three protein isoforms with distinct C-termini: RET9, RET51, and RET43. These RET isoforms show differential binding to downstream adapter molecules, suggesting they may have distinct signaling functions. We have characterized Ret 3' sequences in mouse and investigated alternative splicing of this region. We found that the organization of Ret 3' sequences is very similar to human RET. The mouse locus also has alternatively spliced C-terminal coding regions, and the sequences corresponding to RET9 and RET51 are highly conserved in both position and sequence with the human locus. Further, we compared the predicted C-terminal amino acids of RET9 and RET51 in seven vertebrate species, and found that they are well conserved. We have identified sequence encoding a putative ret43 isoform in mouse, however the predicted amino acid sequence showed low homology to human RET43. Our data suggest that RET isoforms are evolutionarily highly conserved over a broad range of species, which may indicate that each isoform has a distinct role in normal RET function. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12063395     DOI: 10.1159/000059341

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  10 in total

Review 1.  Genetic interactions and modifier genes in Hirschsprung's disease.

Authors:  Adam S Wallace; Richard B Anderson
Journal:  World J Gastroenterol       Date:  2011-12-07       Impact factor: 5.742

Review 2.  RET revisited: expanding the oncogenic portfolio.

Authors:  Lois M Mulligan
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

3.  Differential expression of RET isoforms in normal thyroid tissues, papillary and medullary thyroid carcinomas.

Authors:  Teresa Ramone; Cristina Romei; Raffaele Ciampi; Alessia Tacito; Paolo Piaggi; Liborio Torregrossa; Clara Ugolini; Rossella Elisei
Journal:  Endocrine       Date:  2019-07-05       Impact factor: 3.633

Review 4.  The developmental etiology and pathogenesis of Hirschsprung disease.

Authors:  Naomi E Butler Tjaden; Paul A Trainor
Journal:  Transl Res       Date:  2013-03-22       Impact factor: 7.012

5.  Proteomic Identification of DNA-PK Involvement within the RET Signaling Pathway.

Authors:  Lyle J Burdine; Marie Schluterman Burdine; Linley Moreland; Brad Fogel; Lisa M Orr; Jennifer James; Richard H Turnage; Alan J Tackett
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

6.  Artemin and an Artemin-Derived Peptide, Artefin, Induce Neuronal Survival, and Differentiation Through Ret and NCAM.

Authors:  Mirolyuba Ilieva; Janne Nielsen; Irina Korshunova; Kamil Gotfryd; Elisabeth Bock; Stanislava Pankratova; Tanja Maria Michel
Journal:  Front Mol Neurosci       Date:  2019-02-22       Impact factor: 5.639

7.  Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine.

Authors:  Vishnu Muthuraj Kumarasamy; Yoon-Joo Shin; John White; Daekyu Sun
Journal:  BMC Cancer       Date:  2015-08-26       Impact factor: 4.430

Review 8.  Multiple Endocrine Neoplasia Syndromes from Genetic and Epigenetic Perspectives.

Authors:  Fatemeh Khatami; Seyed Mohammad Tavangar
Journal:  Biomark Insights       Date:  2018-07-02

Review 9.  RET Receptor Tyrosine Kinase: Role in Neurodegeneration, Obesity, and Cancer.

Authors:  Arun Kumar Mahato; Yulia A Sidorova
Journal:  Int J Mol Sci       Date:  2020-09-26       Impact factor: 5.923

10.  Exon Skipping in the RET Gene Encodes Novel Isoforms That Differentially Regulate RET Protein Signal Transduction.

Authors:  Nicole A Gabreski; Janki K Vaghasia; Silvia S Novakova; Neil Q McDonald; Brian A Pierchala
Journal:  J Biol Chem       Date:  2016-05-23       Impact factor: 5.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.